Roanna Ruiz
Stock Analyst at Leerink Partners
(1.96)
# 3,232
Out of 4,516 analysts
447
Total ratings
45.9%
Success rate
0.3%
Average return
Main Sectors:
Stocks Rated by Roanna Ruiz
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KARD Kardigan | Initiated Coverage: Buy | $37 | $21.99 | +68.26% | 1 | Jul 13, 2026 | |
| UTHR United Therapeutics | Maintained: Buy | n/a | $531.79 | - | 26 | Jun 29, 2026 | |
| VIR Vir Biotechnology | Reiterated: Buy | n/a | $9.61 | - | 33 | May 27, 2026 | |
| CRMD CorMedix | Reiterated: Buy | $13 → $15 | $8.42 | +78.15% | 11 | May 15, 2026 | |
| IBIO iBio, Inc. | Maintained: Buy | $5 → $6 | $1.43 | +319.58% | 3 | May 15, 2026 | |
| AQST Aquestive Therapeutics | Reiterated: Buy | $9 | $3.95 | +127.85% | 24 | May 15, 2026 | |
| MNKD MannKind | Maintained: Buy | n/a | $4.09 | - | 1 | Feb 25, 2026 | |
| CYTK Cytokinetics | Reiterated: Buy | n/a | $82.62 | - | 30 | Jan 13, 2026 | |
| TRVI Trevi Therapeutics | Reiterated: Buy | $16 | $18.15 | -11.82% | 1 | Nov 18, 2025 | |
| ENTA Enanta Pharmaceuticals | Maintained: Hold | $7 → $9 | $13.23 | -31.97% | 37 | Oct 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1.00 → $2.00 | $1.04 | +92.31% | 8 | Aug 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $1.38 | +407.25% | 6 | Aug 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $99 | $104.32 | -5.10% | 53 | Aug 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $8.70 | +3.45% | 35 | Aug 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $7.55 | +270.86% | 27 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1 | $2.20 | -54.55% | 17 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $107 → $44 | $31.98 | +37.59% | 27 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $11 | $5.30 | +107.55% | 11 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $10 | $14.46 | -30.84% | 30 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $134.71 | n/a | 2 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $5 → $4 | $4.86 | n/a | 23 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $25 | $5.77 | n/a | 22 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $23 | $89.57 | n/a | 6 | Jan 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $80 | $0.000001 | n/a | 13 | Dec 20, 2022 |
Kardigan
Jul 13, 2026
Initiated Coverage: Buy
Price Target: $37
Current: $21.99
Upside: +68.26%
United Therapeutics
Jun 29, 2026
Maintained: Buy
Price Target: n/a
Current: $531.79
Upside: -
Vir Biotechnology
May 27, 2026
Reiterated: Buy
Price Target: n/a
Current: $9.61
Upside: -
CorMedix
May 15, 2026
Reiterated: Buy
Price Target: $13 → $15
Current: $8.42
Upside: +78.15%
iBio, Inc.
May 15, 2026
Maintained: Buy
Price Target: $5 → $6
Current: $1.43
Upside: +319.58%
Aquestive Therapeutics
May 15, 2026
Reiterated: Buy
Price Target: $9
Current: $3.95
Upside: +127.85%
MannKind
Feb 25, 2026
Maintained: Buy
Price Target: n/a
Current: $4.09
Upside: -
Cytokinetics
Jan 13, 2026
Reiterated: Buy
Price Target: n/a
Current: $82.62
Upside: -
Trevi Therapeutics
Nov 18, 2025
Reiterated: Buy
Price Target: $16
Current: $18.15
Upside: -11.82%
Enanta Pharmaceuticals
Oct 1, 2025
Maintained: Hold
Price Target: $7 → $9
Current: $13.23
Upside: -31.97%
Aug 25, 2025
Reiterated: Hold
Price Target: $1.00 → $2.00
Current: $1.04
Upside: +92.31%
Aug 22, 2025
Reiterated: Buy
Price Target: $7
Current: $1.38
Upside: +407.25%
Aug 22, 2025
Maintained: Buy
Price Target: $99
Current: $104.32
Upside: -5.10%
Aug 20, 2025
Reiterated: Buy
Price Target: $9
Current: $8.70
Upside: +3.45%
Aug 14, 2025
Reiterated: Buy
Price Target: $28
Current: $7.55
Upside: +270.86%
Aug 7, 2025
Reiterated: Hold
Price Target: $1
Current: $2.20
Upside: -54.55%
Aug 7, 2025
Reiterated: Buy
Price Target: $107 → $44
Current: $31.98
Upside: +37.59%
Aug 5, 2025
Reiterated: Buy
Price Target: $10 → $11
Current: $5.30
Upside: +107.55%
Jul 31, 2025
Reiterated: Hold
Price Target: $10
Current: $14.46
Upside: -30.84%
Mar 6, 2025
Maintained: Buy
Price Target: n/a
Current: $134.71
Upside: n/a
May 14, 2024
Maintained: Hold
Price Target: $5 → $4
Current: $4.86
Upside: n/a
May 7, 2024
Maintained: Hold
Price Target: $25
Current: $5.77
Upside: n/a
Jan 22, 2024
Maintained: Hold
Price Target: $23
Current: $89.57
Upside: n/a
Dec 20, 2022
Reiterated: Hold
Price Target: $80
Current: $0.000001
Upside: n/a